Get the Stockscreener App
92.16
0.23%
0.21
Oruka Therapeutics Inc stock is traded at $92.16, with a volume of 578.91K.
It is up +0.23% in the last 24 hours and up +12.27% over the past month.
Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially modify disease by targeting mechanisms with efficacy and safety involved in disease pathology and the activity of pathogenic tissue-resident memory T cells (TRMs). Its program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and other conditions.
See More
Previous Close:
$91.95
Open:
$92.51
24h Volume:
578.91K
Relative Volume:
0.34
Market Cap:
$5.56B
Revenue:
-
Net Income/Loss:
$-116.25M
P/E Ratio:
-38.54
EPS:
-2.3912
Net Cash Flow:
$-91.19M
1W Performance:
-0.58%
1M Performance:
+12.27%
6M Performance:
+167.98%
1Y Performance:
+547.65%
1-Day Range:
$90.32
$94.49
1-Week Range:
$89.79
$96.27
52-Week Range:
$12.84
$97.78
Oruka Therapeutics Inc Stock (ORKA) Company Profile
Name
Oruka Therapeutics Inc
Sector
Industry
Phone
650-606-7910
Address
855 OAK GROVE AVE., MENLO PARK
Compare ORKA vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
92.16 | 5.56B | 0 | -116.25M | -91.19M | -2.3912 |
VRTX
Vertex Pharmaceuticals Inc
|
477.36 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
656.01 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
918.22 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.23 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
271.77 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-25 | Initiated | Piper Sandler | Overweight |
| Nov-13-25 | Initiated | Jefferies | Buy |
| Oct-27-25 | Initiated | Guggenheim | Buy |
| Oct-13-25 | Initiated | Barclays | Overweight |
| May-22-25 | Initiated | BTIG Research | Buy |
| Feb-04-25 | Initiated | Wolfe Research | Outperform |
| Oct-11-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | H.C. Wainwright | Buy |
| Sep-17-24 | Initiated | Leerink Partners | Outperform |
| Sep-16-24 | Initiated | TD Cowen | Buy |
| Sep-13-24 | Initiated | Jefferies | Buy |
| Feb-27-18 | Initiated | Ascendiant Capital Markets | Buy |
| Oct-09-13 | Initiated | Dawson James | Buy |
View All
Oruka Therapeutics Inc Stock (ORKA) Latest News
ORKA|Oruka Therapeutics Inc|Price:92.160|Chg%:+0.210 - TradingKey
ORKA Stock Is Soaring After Psoriasis Trial Results — Here's Why BTIG Hiked Its Price Target By 94% - Stocktwits
Oruka Therapeutics Inc. (ORKA) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
ORKA Stock Climbs As Traders Track Tight Range - StocksToTrade
ORKA Stock Grinds Higher As Traders Track Tight Range - timothysykes.com
ORKA Stock Climbs As Traders Track Strong Cash Runway - StocksToTrade
Oruka Therapeutics Rises as Investors Focus on Pipeline Data Setup - Quiver Quantitative
Form 144 ORUKA THERAPEUTICS INC For: 15 July By Investing.com - Investing.com Australia
Oruka Therapeutics CMO Joana Goncalves sells $603,937 in shares - Investing.com UK
Form 4 Oruka Therapeutics Inc For: 15 July By Investing.com - Investing.com Nigeria
Oruka Therapeutics CMO Joana Goncalves sells $603,937 in shares By Investing.com - Investing.com Nigeria
Form 4 Oruka Therapeutics Inc For: 15 July - Investing.com UK
Form 144 ORUKA THERAPEUTICS INC For: 15 July - Investing.com UK
BTIG Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $151 - Moomoo
Form 4 Oruka Therapeutics Inc For: 13 July By Investing.com - Investing.com South Africa
Oruka Therapeutics SVP sells $846k in stock By Investing.com - Investing.com Nigeria
Form 144 Oruka Therapeutics For: 13 July By Investing.com - Investing.com Australia
Oruka Therapeutics Insider Sold Shares Worth $846,180, According to a Recent SEC Filing - Moomoo
Oruka Therapeutics SVP sells $846k in stock - Investing.com
Form 144 Oruka Therapeutics For: 13 July - Investing.com UK
Oruka TherapeuticsIntriguing Long Acting Psoriasis Programs May Need Further Derisking - Seeking Alpha
How Investors May Respond To Oruka Therapeutics (ORKA) Russell Index Shift Toward Small-Cap Growth Benchmarks - simplywall.st
Oruka Therapeutics Shares Drop After Hours After Fairmount Unloads 3.55 Million Shares - MSN
Oruka Therapeutics (ORKA) Recast By Russell Growth Shift On A Valuation That Looks About Right - Sahm
Why Oruka Therapeutics (ORKA) Is Up 13.6% After Russell Index Reclassification Into Growth Benchmarks - Sahm
UBS Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $130 - Moomoo
Oruka Therapeutics (ORKA) Sees 8.1% Decline - GuruFocus
Oruka Therapeutics Insider Sold Shares Worth $472,079, According to a Recent SEC Filing - marketscreener.com
Fairmount Healthcare Fund II sells $300m Oruka Therapeutics stock By Investing.com - Investing.com India
Form 144 | Oruka Therapeutics(ORKA.US) Insider Proposes to Sell 300.01 Million in Common Stocks - Moomoo
Insider Sell: Laura Sandler Sells 5,000 Shares of Oruka Therapeu - GuruFocus
Form 144 Oruka Therapeutics For: 1 July By Investing.com - Investing.com Nigeria
Form 13D/A ORUKA THERAPEUTICS For: 1 July By Investing.com - Investing.com Nigeria
Fairmount Healthcare Fund II sells $300m Oruka Therapeutics stock - Investing.com
Form 144 Oruka Therapeutics For: 1 July - Investing.com UK
Oruka Therapeutics COO Laura Sandler sells $472,078 in stock - Investing.com
Oruka Therapeutics COO Laura Sandler sells $472,078 in stock By Investing.com - Investing.com South Africa
Form 4 Oruka Therapeutics Inc For: 1 July By Investing.com - Investing.com India
Form 4 Oruka Therapeutics Inc For: 1 July - Investing.com UK
Oruka Therapeutics Inc Stock (ORKA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Oruka Therapeutics Inc Stock (ORKA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Goncalves Joana | Chief Medical Officer |
Jul 15 '26 |
Sale |
86.28 |
7,000 |
603,938 |
32,718 |
0.46%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):